June 2022—Versant Diagnostics has announced a strategy in which the company will focus on anatomic pathology, precision medicine, and the digital transformation of the industry. The company said it is positioning itself to become the nation’s largest independent physician services company through the acquisition of independent pathology practices, and it will provide capital for practices to convert to digital pathology while maintaining physician leadership.
“Our goal is to be a leading catalyst in improving medical diagnostics through the convergence of the latest technology and leading physicians,” Jim Billington, chief executive officer, said in a press statement.
Versant Diagnostics’ practice areas include urology, dermatology, women’s health, gastroenterology, and hematology. The company is supported by more than $100 million in growth capital in partnership with private equity firm Iron Path Capital.
Versant Diagnostics, 817-938-7241